Cipla Ltd Quarterly Results
Q2 FY25-26 Results Summary
Revenue
The revenue stands at ₹7,589.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.08 per cent from ₹6,957.47 crore. This corresponds to a year-on-year *(YoY) growth of 7.64 per cent.
Operating Profit
Operating Profit stands at ₹282.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.49 per cent from ₹272.61 crore. This corresponds to a year-on-year *(YoY) growth of 36.95 per cent.
PBDT
PBDT stands at ₹797.45 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.15 per cent from ₹730.60 crore. This corresponds to a year-on-year *(YoY) growth of 5.65 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,853.83 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.77 per cent from ₹1,769.49 crore. This corresponds to a year-on-year *(YoY) growth of 3.68 per cent.
Net Profit
Net Profit stands at ₹1,351.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.13 per cent from ₹1,297.62 crore. This represents a 3.73 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Cipla Ltd News
Cipla Ltd Earnings
- YOY
- QOQ
Cipla Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Cipla Ltd Research Reports
Cipla Ltd Financial Reports
Cipla Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Cipla | 1.07% | 0.15% | -0.62% | -0.55% | 0.67% | -1.97% |
| Sun Pharma.Inds. | -0.09% | 0.00% | -4.39% | 5.21% | 2.46% | -8.46% |
| Divi's Lab. | -0.53% | -0.49% | -0.39% | 8.94% | -6.85% | 4.04% |
| Torrent Pharma. | 0.51% | 0.71% | 2.99% | 9.28% | 14.68% | 11.43% |
| Dr Reddy's Labs | 0.48% | 0.23% | -0.34% | 1.91% | 0.02% | -7.40% |
| Lupin | 1.49% | -0.04% | 1.37% | 7.10% | 7.34% | -11.86% |
| Zydus Lifesci. | 1.16% | 0.14% | -3.15% | -7.69% | -8.32% | -7.85% |
Company Info
Company Information
Chairman (Non-Executive) : Y K Hamied
Non Executive Director : Adil Zainulbhai
Managing Director & Global CEO : Umang Vohra
Company Sec. & Compli. Officer : Rajendra Chopra
Independent Director : Robert A Stewart
Independent Director : P R Ramesh
Independent Director : Mandar Purushottam Vaidya
Non Executive Director : Abhijit A Joshi
Non Executive Director : Kamil Hamied
Independent Director : Sharmila Paranjpe
Independent Director : Maya Hari
Independent Director : Dr Balram Bhargava
